Skip to main content

Effects of Psilocybin Microdosing on Cognition, Mood and Quality of Life: A Pilot Study

Phase: EARLY_PHASE1 | Sponsor: Yale University | Compound: Psilocybin

Status
planned
Institution
Yale University
Start date
2026-04-01
End date
2028-04-01
Registry ID
NCT07449351

View trial record

Tracked by the DMT Code Clinical Trials Observatory, an open record of DMT-related clinical research.